Compound 401 is a synthetic DNA-PK inhibitor (IC50 = 0.28 μM) that also targets mTOR but not PI3K.

Compound 401 is a synthetic DNA-PK inhibitor (IC50 = 0.28 μM) that also targets mTOR but not PI3K.

Compound 401 is a synthetic DNA-PK inhibitor (IC50 = 0.28 μM) that also targets mTOR but not PI3K.

Compound 48/80, also known as Poly-p-methoxyphenethylmethylamine, is a commonly utilized mast cell activator in animal and tissue models. This compound exerts its effect by stimulating trimeric G-proteins at the mast cell membrane, triggering degranulation through both phospholipase C and D pathways.

Compound 48/80 trihydrochloride is a mixture of N-methyl-p-methoxyphenethylamine and formaldehyde in a condensation reaction.Compound 48/80 trihydrochloride is a mast cell degranulator and histamine releaser. Compound 48/80 trihydrochloride inhibits phosphatidylinositol-specific phospholipase C activity in human platelets.

Compound 48/80 trihydrochloride is a mixture of N-methyl-p-methoxyphenethylamine and formaldehyde in a condensation reaction.Compound 48/80 trihydrochloride is a mast cell degranulator and histamine releaser. Compound 48/80 trihydrochloride inhibits phosphatidylinositol-specific phospholipase C activity in human platelets.

Compound 8H is an inducer of G2/M-phase cell cycle arrest and cell death in cancer cell lines.

Compound 8H is an inducer of G2/M-phase cell cycle arrest and cell death in cancer cell lines.

Compound 8H is an inducer of G2/M-phase cell cycle arrest and cell death in cancer cell lines.

Compound AMTHAMINE DIHYDROBROMIDE is a useful organic compound for research related to life sciences. The catalog number is T67829 and the CAS number is 142437-67-0.

Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.

Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.

Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.

Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.

Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.

Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.

Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.

Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II.

Compound E is an inhibitor of γ-secretase . Compound E bloks β-amyloid(40), β-amyloid(42), and Notch γ-secretase cleavage with IC 50 s of 0.24, 0.37, 0.32 nM, respectively.

Compound E is an inhibitor of γ-secretase . Compound E bloks β-amyloid(40), β-amyloid(42), and Notch γ-secretase cleavage with IC 50 s of 0.24, 0.37, 0.32 nM, respectively.

Compound F0401-0089 is a useful organic compound for research related to life sciences. The catalog number is T91266 and the CAS number is 5468-37-1.

Compound F0401-0089 is a useful organic compound for research related to life sciences. The catalog number is T91266 and the CAS number is 5468-37-1.

Compound F0415-0075 is a useful organic compound for research related to life sciences. The catalog number is T98006 and the CAS number is 2051-07-2.

Compound F0415-0075 is a useful organic compound for research related to life sciences. The catalog number is T98006 and the CAS number is 2051-07-2.

hiCE inhibitor-1 is a sulfonamide derivative that is a selective human intestinal enzyme ( hiCE ) inhibitor with a K i value of 53.3 nM. hiCE inhibitor-1 can be used to improve Irinotecan -induced diarrhoea [1].

hiCE inhibitor-1 is a sulfonamide derivative that is a selective human intestinal enzyme ( hiCE ) inhibitor with a K i value of 53.3 nM. hiCE inhibitor-1 can be used to improve Irinotecan -induced diarrhoea [1].

hiCE inhibitor-1 is a sulfonamide derivative that is a selective human intestinal enzyme ( hiCE ) inhibitor with a K i value of 53.3 nM. hiCE inhibitor-1 can be used to improve Irinotecan -induced diarrhoea [1].

Antitubercular agent-33 is a 2-aminothiazole derivative with potent anti-tubercular activity against Mycobacterium tuberculosis ( Mtb ) [1].

Antitubercular agent-33 is a 2-aminothiazole derivative with potent anti-tubercular activity against Mycobacterium tuberculosis ( Mtb ) [1].

Antitubercular agent-33 is a 2-aminothiazole derivative with potent anti-tubercular activity against Mycobacterium tuberculosis ( Mtb ) [1].